01 November 2024

REBORN project has been highlighted in the prestigious Innovation section of the Official Newspaper of the 38th EACTS (European Association for Cardio-Thoracic Surgery) Annual Meeting 2024! This recognition underscores the groundbreaking nature of our work and its potential impact on the field of myocardial regeneration.

Under the title “Piezoelectric patch enriched with smart ultrasound-responsive nanocarriers for controlled drug release for myocardial regeneration”, our project was showcased as a revolutionary approach to cardiac recovery.

Our inclusion in the Innovation section at EACTS 2024 is a significant endorsement of the REBORN project’s potential to transform post-infarction cardiac care. Stay tuned for further updates as we continue to make strides in this important research.

Find out more and read the article here.